Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-22-006577

Chairman & CEO acquired 21,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-03 Grant or award : show line 1 in the form +21,250 100,521.82 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-05-03 Grant or award : show line 2 in the form Employee Stock Option (Right to Acquire) +190,400 $105.93 2029-05-02 190,400 190,400 D
2022-05-03 Grant or award : show line 3 in the form Performance Rights +26,550 26,550 26,550 D
Loading xslF345X03/doc4.xml…